Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing

Official title: Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma

Run by University Hospital, Bordeaux · NCT07802769 · Data updated 2026-11-12

This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedAugust 28, 2026
Main results expectedMay 2027
Study endsMay 2027
Registry record updatedSeptember 3, 2026
Trial IDNCT07802769 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who completed the ENVOL study and are willing to participate in follow-up imaging and ophthalmic assessments in France.

Probably not a fit

Patients who did not complete the ENVOL study or are unable to undergo MRI or ophthalmic evaluations may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The EVOLUTION study is a 10-year extension that uses 3T MRI to compare brain structure and connectivity between people with glaucoma and matched healthy controls, building on previous ENVOL data. It looks for changes in cerebral volume and network connectivity (Hub Disruption Index) to understand whether glaucomatous damage extends beyond the optic pathway. Participants undergo ophthalmic exams and a non-invasive brain scan, with repeat imaging and eye assessments to track glaucoma progression. The study is observational in design, focusing on longitudinal imaging and clinical correlations. It intends to clarify whether glaucoma is associated with broader CNS degeneration beyond the visual system.

Why it matters

Potential benefit: If successful, this work could improve understanding of glaucoma as a potential brain-wide condition and inform future monitoring and therapeutic strategies.

How similar studies have gone: Previous work with ENVOL showed microstructural changes in optic pathways; this extension aims to extend those findings with longitudinal brain imaging.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* having been previously included and completed the ENVOL study
* Ability and willingness to provide informed consent
* Having a valid health insurance in France

In glaucoma group :

* Glaucomatous optic neuropathy, being able to be graded by the vertical C/D ratio
* Open angle on gonioscopy in a dark-room testing according to Shaffer's classification (grade 3 or grade 4)
* Visual field impairement (at least one of the following) :

  * 3 adjacent points with at least 5dB loss
  * one point with a loss of 10dB
  * a difference of at least 10 dB for 2 adjacent points on either side of the horizontal meridian of the nasal visual field
* Mini Mental State Score of at least 28

In control group :

* No personal or family history of glaucoma or ocular hypertension (IOP \> 21 mmHg)
* Open angle on gonioscopy in a dark-room testing according to Shaffer's classification (grade 3 or grade 4)
* Intraocular pressure of ≤ 21 mmHg
* Absence of glaucomatous neuropathy
* Normal visual field

Exclusion Criteria:

* Inability/unwillingness to provide informed consent
* Other causes of ocular hypertension (trauma, uveitis)
* Non-glaucomatous optic neuropathy (infectious, inflammatory, compressive, ischemic)
* Unreliable visual field (\>15% false positives, \>33% false negatives or \>20% loss of fixation)
* Severe corneal pathology preventing access to fundus, visual field testing or altering ocular tonometry
* Contraindications to MRI testing (pacemakers or neurosensory stimulators, cochlear implants, ferromagnetic foreign bodies, claustrophobia)
* Patients under guardianship or other form of legal protection

Where it's running

  • CHU Bordeaux
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.